Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linjie Li

Showing results (171-180 of 193) with videos related to

Pageof 20
Sort By:
Journal of the American Heart Association|February 27, 2023
Third-Trimester Maternal Serum Chemerin and Hypertension After Preeclampsia: A Prospective Cohort StudyYixuan Chen, Linlin Wu, Hangkuan Liu, et al.
The Science of the Total Environment|November 25, 2019
High daytime abundance of primary organic aerosols over Mt. Emei, Southwest China in summerYue Zhao, Hong Ren, Junjun Deng, et al.
Cell Discovery|July 12, 2022
Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2sLinjie Li, Pu Han, Baihan Huang, et al.
National Science Review|October 3, 2022
Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animalsShihua Li, Ruirui Yang, Di Zhang, et al.
Cell|April 14, 2026
Rational design of G<sub>i</sub>-biased CB1 agonist with reduced side effectsYu-Ying Liao, Jinxin Che, Yun-Tao Gao, et al.
Cell|January 30, 2022
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2Pengcheng Han, Linjie Li, Sheng Liu, et al.
Journal of Pharmaceutical Analysis|June 26, 2023
Licorice-saponin A3 is a broad-spectrum inhibitor for COVID-19 by targeting viral spike and anti-inflammationYang Yi, Wenzhe Li, Kefang Liu, et al.
International Journal of Cancer|December 26, 2024
Synchronous bilateral Wilms tumors are prone to develop independently and respond differently to preoperative chemotherapyTing Tao, Shuangai Liu, Min He, et al.
Platelets|January 3, 2023
Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics studyXiaofan Liu, Yusheng Bai, Tao Wang, et al.
Plos Pathogens|August 30, 2024
Protective RBD-dimer vaccines against SARS-CoV-2 and its variants produced in glycoengineered Pichia pastorisTongxin Zhao, Sheng Liu, Pengyan Wang, et al.
Pageof 20

Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
Journal of the American Heart Association|February 27, 2023
Third-Trimester Maternal Serum Chemerin and Hypertension After Preeclampsia: A Prospective Cohort StudyYixuan Chen, Linlin Wu, Hangkuan Liu, et al.
The Science of the Total Environment|November 25, 2019
High daytime abundance of primary organic aerosols over Mt. Emei, Southwest China in summerYue Zhao, Hong Ren, Junjun Deng, et al.
Cell Discovery|July 12, 2022
Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2sLinjie Li, Pu Han, Baihan Huang, et al.
National Science Review|October 3, 2022
Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animalsShihua Li, Ruirui Yang, Di Zhang, et al.
Cell|April 14, 2026
Rational design of G<sub>i</sub>-biased CB1 agonist with reduced side effectsYu-Ying Liao, Jinxin Che, Yun-Tao Gao, et al.
Cell|January 30, 2022
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2Pengcheng Han, Linjie Li, Sheng Liu, et al.
Journal of Pharmaceutical Analysis|June 26, 2023
Licorice-saponin A3 is a broad-spectrum inhibitor for COVID-19 by targeting viral spike and anti-inflammationYang Yi, Wenzhe Li, Kefang Liu, et al.
International Journal of Cancer|December 26, 2024
Synchronous bilateral Wilms tumors are prone to develop independently and respond differently to preoperative chemotherapyTing Tao, Shuangai Liu, Min He, et al.
Platelets|January 3, 2023
Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics studyXiaofan Liu, Yusheng Bai, Tao Wang, et al.
Plos Pathogens|August 30, 2024
Protective RBD-dimer vaccines against SARS-CoV-2 and its variants produced in glycoengineered Pichia pastorisTongxin Zhao, Sheng Liu, Pengyan Wang, et al.
Pageof 20